Soundwaves LLC recently announced the diversification of its portable ultrasound services beyond obstetrics and gynecology to other medical disciplines, including cardiology, and the expansion of its operations from South Florida to the Mid-Atlantic.

Blue Earth Diagnostics announced that the Trial Steering Committee recommended further recruitment be stopped in the FALCON clinical study of fluciclovine (18F) PET/CT imaging, based on successful results of a pre-planned interim analysis. The FALCON trial, announced in March 2016, is a U.K.-based, open-label study (NCT02578940) to evaluate the clinical impact of fluciclovine (18F) positron emission tomography/computed tomography (PET/CT) imaging on patient management decisions in men with biochemically recurrent prostate cancer.

RaySearch demonstrated a new Monte Carlo dose planning feature for proton therapy on its RayStation system at the 2017 Particle Therapy Co-Operative Group (PTCOG) conference, May 8-13 in Yokohama, Japan.

Carestream Health is demonstrating new imaging analytics tools that are being added to its Clinical Collaboration Platform at the upcoming Society for Imaging Informatics in Medicine (SIIM) conference, June 1-3 in Pittsburgh. These new capabilities are designed to equip healthcare providers to deliver preventative care.

The webinar "Advances in Computed Tomography (CT) to Enhance Radiation Therapy Planning," will offer an overview of the use of CT simulation in radiation therapy and the technologies available to reduce image artifacts that may impact the quality of care. 

A study in 65 countries has revealed low adoption of International Atomic Energy Agency (IAEA) recommendations to reduce nuclear cardiology radiation exposure. The research was presented at ICNC 2017, May 7-9 in Vienna Austria, by Edward Hulten, M.D., a cardiologist at the Walter Reed National Military Medical Center, Bethesda, Md.

A new research study concluded that use of the BioZorb surgical marker appears to provide better cosmetic outcomes and may be associated with an increased use of breast-conserving surgery. The study was conducted by Arkansas surgical oncologist Michael Cross, M.D., F.A.C.S.

Scranton Gillette Communications’ Imaging Technology News (ITN) was recently named a 2017 Azbee Award winner in two Upper Midwest Regional categories. The annual Azbee Awards are hosted by the American Society of Business Publication Editors (ASBPE) to recognize editorial and design excellence in the business, trade and specialty press.

May 11, 2017 — Accuray Inc. announced that studies on the clinical use of the CyberKnife System continue to demonstrate its benefits across a wide range of cancer indications and stages in the cancer treatment journey. More than 50 studies were presented during poster and oral sessions at the 36th Annual European Society for Radiotherapy & Oncology (ESTRO) Meeting in Vienna, Austria, May 5 - 9, 2017.

A large nuclear cardiology laboratory in Missouri has slashed its average radiation dose by 60 percent in eight years, according to new research presented at ICNC 2017, May 7-9 in Vienna, Austria and published in JACC:Cardiovascular Imaging.1,2 The study in over 18,000 patients showed dose reductions were achieved despite a large number of obese patients.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now